| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |